169 related articles for article (PubMed ID: 31155507)
21. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
Tong Z; Guo J; Glen RC; Morrell NW; Li W
Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
[TBL] [Abstract][Full Text] [Related]
22. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
[TBL] [Abstract][Full Text] [Related]
23. Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cells.
Wang J; Liu W; Lu W; Luo X; Lin Y; Liu S; Qian J; Zhang C; Chen H; Li Y; Li X; Chen J; Chen Y; Jiang Q; Liu C; Hong C; Wang T; Tang H; Zhong N; Yang J; Yang K; Sun D
Biochem Pharmacol; 2022 May; 199():114986. PubMed ID: 35276216
[TBL] [Abstract][Full Text] [Related]
24. EGF-like-domain-7 is required for VEGF-induced Akt/ERK activation and vascular tube formation in an ex vivo angiogenesis assay.
Takeuchi K; Yanai R; Kumase F; Morizane Y; Suzuki J; Kayama M; Brodowska K; Nakazawa M; Miller JW; Connor KM; Vavvas DG
PLoS One; 2014; 9(3):e91849. PubMed ID: 24647208
[TBL] [Abstract][Full Text] [Related]
25. EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia.
Bill M; Pathmanathan A; Karunasiri M; Shen C; Burke MH; Ranganathan P; Papaioannou D; Zitzer NC; Snyder K; LaRocco A; Walker AE; Brannan ZJ; Nalin AP; Freud AG; Dikov MM; Zhang X; Bloomfield CD; Garzon R; Dorrance AM
Clin Cancer Res; 2020 Feb; 26(3):669-678. PubMed ID: 31672772
[TBL] [Abstract][Full Text] [Related]
26. Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts.
Liakouli V; Cipriani P; Di Benedetto P; Panzera N; Ruscitti P; Pantano I; Berardicurti O; Carubbi F; Esteves F; Mavria G; Del Galdo F; Giacomelli R
Sci Rep; 2019 Mar; 9(1):4589. PubMed ID: 30872612
[TBL] [Abstract][Full Text] [Related]
27. MxA Is a Novel Regulator of Endosome-Associated Transcriptional Signaling by Bone Morphogenetic Proteins 4 and 9 (BMP4 and BMP9).
Yuan H; Sehgal PB
PLoS One; 2016; 11(11):e0166382. PubMed ID: 27875556
[TBL] [Abstract][Full Text] [Related]
28. EPDR1 is a noncanonical effector of insulin-mediated angiogenesis regulated by an endothelial-specific TGF-β receptor complex.
Ahmed T; Flores PC; Pan CC; Ortiz HR; Lee YS; Langlais PR; Mythreye K; Lee NY
J Biol Chem; 2022 Sep; 298(9):102297. PubMed ID: 35872017
[TBL] [Abstract][Full Text] [Related]
29. Discovering the role of VEGF signaling pathway in mesendodermal induction of human embryonic stem cells.
Xin C; Zhu C; Jin Y; Li H
Biochem Biophys Res Commun; 2021 May; 553():58-64. PubMed ID: 33756346
[TBL] [Abstract][Full Text] [Related]
30. Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7.
Nichol D; Shawber C; Fitch MJ; Bambino K; Sharma A; Kitajewski J; Stuhlmann H
Blood; 2010 Dec; 116(26):6133-43. PubMed ID: 20947685
[TBL] [Abstract][Full Text] [Related]
31. LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus.
Zhou Q; Yu B; Anderson C; Huang ZP; Hanus J; Zhang W; Han Y; Bhattacharjee PS; Srinivasan S; Zhang K; Wang DZ; Wang S
Elife; 2019 Feb; 8():. PubMed ID: 30741632
[TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.
David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S
Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101
[TBL] [Abstract][Full Text] [Related]
33. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
[TBL] [Abstract][Full Text] [Related]
34. [Epidermal growth factor-like domain 7 promotes endothelial cell migration and angiogenesis by activating ERK signaling pathway].
Cao Y; Lyu Q
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):270-3. PubMed ID: 25975912
[TBL] [Abstract][Full Text] [Related]
35. Role of EGFL7 in human cancers: A review.
de Oliveira C; Gonçalves PG; Bidinotto LT
J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
[TBL] [Abstract][Full Text] [Related]
36. The high affinity ALK1-ligand BMP9 induces a hypertrophy-like state in chondrocytes that is antagonized by TGFβ1.
van Caam A; Blaney Davidson E; Garcia de Vinuesa A; van Geffen E; van den Berg W; Goumans MJ; ten Dijke P; van der Kraan P
Osteoarthritis Cartilage; 2015 Jun; 23(6):985-95. PubMed ID: 25681563
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor-like domain 7 is a marker of the endothelial lineage and active angiogenesis.
Bambino K; Lacko LA; Hajjar KA; Stuhlmann H
Genesis; 2014 Jul; 52(7):657-70. PubMed ID: 24740971
[TBL] [Abstract][Full Text] [Related]
38. BMP9 Induces Cord Blood-Derived Endothelial Progenitor Cell Differentiation and Ischemic Neovascularization via ALK1.
Kim J; Kim M; Jeong Y; Lee WB; Park H; Kwon JY; Kim YM; Hwang D; Kwon YG
Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2020-31. PubMed ID: 26229139
[TBL] [Abstract][Full Text] [Related]
39. A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis.
Kerr G; Sheldon H; Chaikuad A; Alfano I; von Delft F; Bullock AN; Harris AL
Angiogenesis; 2015 Apr; 18(2):209-17. PubMed ID: 25557927
[TBL] [Abstract][Full Text] [Related]
40. Bone morphogenetic protein‑9 promotes the differentiation of mouse spleen macrophages into osteoclasts via the ALK1 receptor and ERK 1/2 pathways in vitro.
Li H; Zhao D; Wang S; Ding J; Zhao L
Mol Med Rep; 2016 Nov; 14(5):4545-4550. PubMed ID: 27748860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
